Croda Chief Executive Steve Foots last year saw his full-year pay crack the £1.4m barrier. This year however, Foots sees his total salary package fall close to 45% to just under £770,000.
Croda's Steve Foots sees salary dive
The Chief Executive's salary falls by 45% on last year
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Analysis: L'Oréal must address what Gucci Beauty stands for in licence takeover
Read moreWith L’Oréal set to acquire Gucci’s beauty licence from Coty sooner than expected, we discuss what the giant can do for the luxury fashion house – from addressing Gucci Beauty’s identity crisis, to building a make-up line that can mature and build equity
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Colour Cosmetics
Analysis: L'Oréal must address what Gucci Beauty stands for in licence takeover
With L’Oréal set to acquire Gucci’s beauty licence from Coty sooner than expected, we discuss what the giant can do for the luxury fashion house – from addressing Gucci Beauty’s identity crisis, to building a make-up line that can mature and build equity
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Ingredients
Inside Dermalogica’s big innovation plans: longevity science, AI and biotechnology
The Unilever-owned heritage player’s innovation pipeline for the next two years sees it ramp up R&D in longevity science, AI-designed functional peptides, sun care filters and biotechnology to ensure better skin barrier health
Colour Cosmetics
Has Estée Lauder Companies decided against selling Dr. Jart+, Too Faced and Smashbox?
After months of speculation that Estée Lauder Companies was allegedly mulling a potential sale of Too Faced, Smashbox and Dr. Jart+, a new report alleges the beauty giant has decided to keep the trio in its portfolio
Ingredients
Nanyang Biologics (NYB) and Sweetch Group partner to advance AI-powered discovery of nature-derived cosmetic ingredients
Nanyang Biologics (NYB) and Sweetch Group, through its subsidiary Laboratoire Greenpharma, today announced a strategic collaboration to accelerate the discovery and development of next-generation nature-derived bioactive ingredients for skincare and cosmetics
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.